fbpx

Neurophyschiatric drugs

19 02, 2020

ISCTM Annual Meeting 2020

2020-01-24T20:17:37+00:00February 19th, 2020|

Recent years have seen a steady increase in the new applications of somatic therapies that target symptom change in interaction with psychotherapeutic interventions. Examples range from use of repetitive transcranial magnetic stimulation combined with symptom provocation for obsessive compulsive disorder, to intranasal oxytocin combined with social cognition training for young people with early psychosis, to [...]

23 07, 2019

Neuropsychiatric Drug Development (NPD)

2020-01-24T17:20:52+00:00July 23rd, 2019|

The 2nd Annual Neuropsychiatric Drug Development Summit (NPD) will unravel the complexities of developing truly clinically transformative neuropsychiatric drugs.